Tag: targeted therapy market demand

  • Top Growth Trends in the Targeted Therapy Market: Insights into Market Size and Opportunities for 2025-2034

    Top Growth Trends in the Targeted Therapy Market: Insights into Market Size and Opportunities for 2025-2034

    2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

    What Are the Primary Drivers Supporting the Market Growth of theTargeted Therapy Market?

    The targeted therapy market is predicted to expand due to the growing incidence of cancer. Cancer describes conditions characterized by abnormal cells that can both invade surrounding tissues and multiply unchecked. Targeted therapy is capable of disabling the signals that stimulate cancer cell growth or prompting these cells to self-terminate. This therapy uses drugs to specifically target genes and proteins responsible for cancer cell proliferation and sustainability, thereby elevating its demand. For example, the American Cancer Society, a US-nonprofit cancer advocacy group, reported in January 2024 that the number of cancer cases rose to 2,001,140 compared to 1,958,310 in 2023, a growth of 2.19%. Consequently, the escalating prevalence of cancer is expected to fuel the growth of the targeted therapy market.

    Get Your Free Sample Report Now – Explore Exclusive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9129&type=smp

    How Will the Growth Rate of theTargeted Therapy Market Impact Industry Trends by 2034?

    The size of the targeted therapy market has expanded significantly in the previous years. Its growth is projected to increase from $103.84 billion in 2024 to $111.47 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. Key factors contributing to the growth in the past period encompass progress made in molecular biology, a rising number of cancer cases, a trend towards personalized medicine, and the approval and support provided by FDA regulations.

    The market size for targeted therapy is projected to experience substantial growth in the coming years, with the expected value reaching $151.48 billion in 2029 and a compound annual growth rate (CAGR) of 8.0%. This predicted growth within the given timeframe can be traced back to factors such as increased oncology research, the growing need for precision medicine, the development of immunotherapies, heightened investment in biopharmaceuticals, and patient consciousness and advocacy. Notable trends for the forecast period encompass the incorporation of artificial intelligence (AI) in drug discovery, patient advocacy and participation in treatment choices, the growth of companion diagnostics, regulatory backing for fast-track approvals, and increased investment in biotech and pharmaceuticals.

    You can Directly Purchase the Report Here:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9129

    What Are the Latest Innovations Influencing theTargeted Therapy Market?

    Major companies in the targeted therapy market are prioritizing the development of novel technological solutions to enhance their market standings. For example, in March 2022, Novartis AG, a multinational pharmaceutical corporation based in Switzerland, initiated the launch of Pluvicto, a product approved by the US Food and Drug Administration (FDA). This product, Pluvicto, is the first FDA-sanctioned targeted radioligand therapy (RLT) for patients eligible with mCRPC. It marries a therapeutic radioisotope with a targeted chemical, forming a type of cancer therapy where a targeting chemical is paired with a therapeutic radioisotope. Pluvicto adheres to target cells in the bloodstream, including prostate cancer cells that express the PSMA transmembrane protein. Upon binding, the energy emissions from the radioisotope harm the target cells and other nearby cells, restricting their replication capabilities and/or causing cell death.

    Who Are the Major Industry Players Accelerating Growth in theTargeted Therapy Market?

    Major companies operating in the targeted therapy market include Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol Myers Squibb, AstraZeneca, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Genmab A/S, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Agilent Technologies Inc., Illumina Inc., Incyte Corporation, Sysmex Corporation, Exact Sciences Corporation, Seagen Inc., Exelixis Inc., Seattle Genetics Inc., Genentech Inc., Daiichi Sankyo Company Limited

    Order Your Report Now For A Swift Delivery:

    https://www.thebusinessresearchcompany.com/report/targeted-therapy-global-market-report

    Which Primary Segments of the Targeted Therapy Market Are Driving Growth and Industry Transformations?

    The targeted therapy market covered in this report is segmented –

    1) By Type: Small Molecule Medicines, Monoclonal Antibodies

    2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

    3) By Application: Breast Cancer, Colorectal Cancer, Leukemia, Lung Cancer, Lymphoma, Renal Cancer, Other Applications

    Subsegments:

    1) By Small Molecule Medicines: Tyrosine Kinase Inhibitors (TKIs), Proteasome Inhibitors, Phosphatidylinositol 3-Kinase (PI3K) Inhibitors, Other Small Molecule Therapies

    2) By Monoclonal Antibodies: Immune Checkpoint Inhibitors, Antibody-Drug Conjugates (ADCs), Cytokine Blockers, Other Monoclonal Antibodies

    Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

    https://www.thebusinessresearchcompany.com/customise?id=9129&type=smp

    Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of theTargeted Therapy Market?# Market?

    North America was the largest region in the targeted therapy market in 2024. The regions covered in the targeted therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Reports Similar to the Global Targeted Therapy Market 2025, By The Business Research Company:

    Tank Wagons Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/tank-wagons-global-market-report

    Boiler, Tank, And Shipping Container Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/boiler-tank-and-shipping-container-global-market-report

    ISO Tank Container Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/iso-tank-container-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Comprehensive Analysis of the Targeted Therapy Market 2025-2034: Growth Rates, Trends, and Future Opportunities

    Comprehensive Analysis of the Targeted Therapy Market 2025-2034: Growth Rates, Trends, and Future Opportunities

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    How has the targeted therapy market grown in recent years?

    The market size for targeted therapy has experienced significant growth in the past few years. It is projected to expand from $103.84 billion in 2024 to $111.47 billion in 2025, signifying a compound annual growth rate (CAGR) of 7.3%. Several factors have contributed to this growth during the historical period, including advances in molecular biology, rising incidences of cancer, a shift towards personalized medicine, support from FDA approvals, and regulatory endorsements.

    How is the targeted therapy market size expected to evolve during the forecast period?

    Get your targeted therapy market report here!

    https://www.thebusinessresearchcompany.com/report/targeted-therapy-global-market-report

    Which key drivers are propelling the targeted therapy market’s growth?

    The escalating numbers of cancer instances are anticipated to drive the expansion of the targeted therapy market in the future. Cancer is a condition characterized by rogue cells that can invade surrounding tissues and proliferate uncontrollably. By interrupting the signals that promote the multiplication of cancer cells or inducing the cancer cells to self-annihilate, targeted therapy aids. This kind of therapy uses drugs engineered specifically to act upon genes and proteins which enable cancer cells to thrive and endure, thus boosting its demand. For example, data from the American Cancer Society, a US-based charity dedicated to cancer advocacy, showed in January 2024, the cancer case count had risen to 2,001,140 from 1,958,310 in 2023, a surge of 2.19%. Therefore, the rising frequency of cancer will be a principal driver for the expansion of the targeted therapy market.

    What are the market segments in the targeted therapy industry?

    The targeted therapy market covered in this report is segmented –

    1) By Type: Small Molecule Medicines, Monoclonal Antibodies

    2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

    3) By Application: Breast Cancer, Colorectal Cancer, Leukemia, Lung Cancer, Lymphoma, Renal Cancer, Other Applications

    Subsegments:

    1) By Small Molecule Medicines: Tyrosine Kinase Inhibitors (TKIs), Proteasome Inhibitors, Phosphatidylinositol 3-Kinase (PI3K) Inhibitors, Other Small Molecule Therapies

    2) By Monoclonal Antibodies: Immune Checkpoint Inhibitors, Antibody-Drug Conjugates (ADCs), Cytokine Blockers, Other Monoclonal Antibodies

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9129&type=smp

    Which leading companies are shaping the growth of the targeted therapy market?

    Major companies operating in the targeted therapy market include Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol Myers Squibb, AstraZeneca, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Genmab A/S, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Agilent Technologies Inc., Illumina Inc., Incyte Corporation, Sysmex Corporation, Exact Sciences Corporation, Seagen Inc., Exelixis Inc., Seattle Genetics Inc., Genentech Inc., Daiichi Sankyo Company Limited

    What key trends are currently impacting the targeted therapy market’s development?

    Leading organizations in the targeted therapy market, such as Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co Inc., and AbbVie Inc., are driving significant operations. Other key players include Bayer AG, Novartis AG, Sanofi SA, Bristol Myers Squibb, and AstraZeneca. Furthermore, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., and Genmab A/S are also significant contributors. Companies like Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Agilent Technologies Inc., and Illumina Inc. are key players, along with Incyte Corporation, Sysmex Corporation, Exact Sciences Corporation, Seagen Inc., Exelixis Inc., Seattle Genetics Inc., Genentech Inc., and Daiichi Sankyo Company Limited.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9129

    Which geographic areas are influencing the growth of the targeted therapy market?

    North America was the largest region in the targeted therapy market in 2024. The regions covered in the targeted therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Similar Reports By The Business Research Company:

    Cell Culture Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

    Cellular Immunotherapy Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cellulars-immunotherapy-global-market-report

    Cellular Telephones Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cellular-telephone-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Unlocking the Future of the Targeted Therapy Market: Growth Rate, Key Trends, and Opportunities for 2025-2034

    Unlocking the Future of the Targeted Therapy Market: Growth Rate, Key Trends, and Opportunities for 2025-2034

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    Analyzing the Growth Rate of the Targeted Therapy Market: What’s the Expected CAGR for the Next Decade?

    The market size for targeted therapy has been expanding robustly over the past few years. It’s estimated to grow from $103.84 billion in 2024 to $111.47 billion in 2025, boasting a compound annual growth rate (CAGR) of 7.3%. The notable growth in the past can be credited to advancements in the field of molecular biology, rise in cancer prevalence, the growing trend of personalised medicine as well as regulatory support and approvals from the FDA.

    The market size for targeted therapy is predicted to experience significant growth in the coming years, expanding to $151.48 billion in 2029 with a compound annual growth rate (CAGR) of 8.0%. This expected growth during the forecast period can be linked to factors such as increased research in oncology, growing demand for precision medicine, the advent of immunotherapies, surge in biopharmaceutical investments, and heightened patient awareness and advocacy. The key trends projected for this period involve harnessing artificial intelligence in drug research, greater patient advocacy and participation in treatment choices, the broadening of companion diagnostics, regulatory backing for speedy approvals, and a rise in investment in biotechnology and pharmaceutical industries.

    Which Major Market Drivers Are Expected to Boost the Targeted Therapy Market’s Growth Potential?

    The targeted therapy market is predicted to expand due to the rising incidence of cancer. Cancer is characterized by abnormal cells that multiply uncontrollably and can invade adjacent tissues. Targeted therapy can inhibit the signals that stimulate cancer cell growth or trigger self-destruction in these cells. This type of therapy utilizes drugs to specifically target the genes and proteins facilitating cancer cell growth and survival, thereby heightening its demand. For example, the American Cancer Society, a nonprofit cancer advocacy organization in the US, reported that the number of cancer cases rose to 2,001,140 in January 2024 from 1,958,310 in 2023, an increase of 2.19%. Thus, the escalating prevalence of cancer is anticipated to fuel the growth of the targeted therapy market.

    Explore Comprehensive Insights Into The Global Targeted Therapy Market With A Free Sample Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9129&type=smp

    What Are the Leading Organizations Impacting the Targeted Therapy Market’s Growth?

    Major companies operating in the targeted therapy market include:

    • Pfizer Inc.

    • Johnson & Johnson

    • F. Hoffmann-La Roche Ltd

    • Merck & Co Inc.

    • AbbVie Inc.

    What Are the Most Prominent Trends Driving Change in the Targeted Therapy Market?

    Leading companies in the targeted therapy market are executing strategies of introducing novel technological solutions to consolidate their presence in the industry. An example of this strategy was observed in March 2022 when Novartis AG, a Swiss multinational pharmaceutical firm, released Pluvicto after receiving approval from the US Food and Drug Administration (FDA). Pluvicto, the inaugural targeted radioligand therapy (RLT) approved by the FDA for apt patients with mCRPC, is a category of targeted cancer therapy that merges a therapeutic radioisotope with a chemical target, known as a radioactive particle. Pluvicto bonds with target cells in the bloodstream, including those prostate cancer cells that showcase the PSMA transmembrane protein. Post bonding, the energy releases from the radioisotope damages the target cells and neighboring cells in the area, thereby inhibiting their ability to replicate and potentially leading to cellular death.

    Secure Your Global Targeted Therapy Market Report Now for Fast and Efficient Delivery!

    https://www.thebusinessresearchcompany.com/report/targeted-therapy-global-market-report

    Which Segments Play a Crucial Role in the Expansion of the Targeted Therapy Market?

    The targeted therapy market covered in this report is segmented –

    1) By Type: Small Molecule Medicines, Monoclonal Antibodies

    2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

    3) By Application: Breast Cancer, Colorectal Cancer, Leukemia, Lung Cancer, Lymphoma, Renal Cancer, Other Applications

    Subsegments:

    1) By Small Molecule Medicines: Tyrosine Kinase Inhibitors (TKIs), Proteasome Inhibitors, Phosphatidylinositol 3-Kinase (PI3K) Inhibitors, Other Small Molecule Therapies

    2) By Monoclonal Antibodies: Immune Checkpoint Inhibitors, Antibody-Drug Conjugates (ADCs), Cytokine Blockers, Other Monoclonal Antibodies

    What Regions Are Leading the Charge in the Targeted Therapy Market?

    North America was the largest region in the targeted therapy market in 2024. The regions covered in the targeted therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    What Does the Definition of the Targeted Therapy Market Include?

    Targeted therapy refers to a kind of cancer treatment that employs medications or other chemicals to attack particular molecules required for the survival and spread of cancer cells. It uses drugs to target specific genes and proteins that help cancer cells survive and grow.

    Browse Through More Similar Reports By The Business Research Company:

    Cell Culture Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

    Cellular Immunotherapy Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cellulars-immunotherapy-global-market-report

    Cellular Telephones Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cellular-telephone-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on: